FDA Warns Purell Against Making Claims It Can Prevent Flu, Ebola

Federal regulators indicate that advertisements for the hand sanitizer Purell may be false and misleading, suggesting that it is effective at preventing Ebola, norovirus, or the flu, none of which have been established by the manufacturer.

On January 17, the FDA issued a warning letter  to GOJO Industries Inc., the maker of Purell products, indicating that they must stop making claims that its products prevent a myriad diseases and illnesses.

As a result of the unproven claims that Purell can cure or treat certain disease, the agency indicates that it is reclassifying the hand sanitizer as an unapproved drug.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

Marketing statements for over-the-counter Purell hand sanitizer products indicate it “kills more than 99.99% of most common germs,” including the bacteria that can cause illnesses like Methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin-resistant Enterococcus (VRE). Some statements claim Purell can lead to “100% MRSA and VRE reduction.”

MRSA is a type of staph infection that is resistant to antibiotics. It is very difficult to treat, and causes more than 80,000 infections and 11,000 deaths in the U.S. every year. VRE is another form of antibiotic resistant bacteria that is difficult to treat, causing thousands of deaths annually.

The FDA also indicates Purell advertisements have claimed it could prevent the flu and help reduce student absenteeism by 51%. In addition, some Purell ads claim the World Health Organization and the U.S. Centers for Disease Control and Prevention (CDC) recommend the use of alcohol-based hand sanitizer to prevent Ebola outbreaks.

Such claims are false or unproven, according to the FDA, and go far beyond what the manufacturer is allowed to claim about Purell in its advertising.

The FDA warning indicates GOJO’s claims violate the Food and Drug Cosmetic Act by claiming the product can cure, treat or prevent a disease. The agency said it is not aware of studies that are well-controlled that adequately show hand sanitizer kills bacteria or viruses and prevent infection or disease caused by those bacteria or virus.

“Your labeling claims that PURELL Healthcare Advanced Hand Sanitizers are effective in preventing disease or infection from pathogens such as Ebola, MRSA, VRE, norovirus, flu, and Candida auris, and in preventing the spread of infection, go beyond merely describing the general intended use of a topical antiseptic as set forth in the above-referenced relevant rulemakings,” the FDA warning letter states.

The reclassification as an unapproved drug puts Purell well under the purview of FDA enforcement. The letter calls for GOJO to fix the advertising claims and other violations promptly, and to notify the agency of how it will address the problems within 15 days of receiving the letter.

The CDC recommends using hand sanitizer only when hand-washing with soap and water is not available. Washing your hands is the best way to prevent the spread of germs and onset of illness, health experts say.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Angiodynamics LifePort Lawsuit Filed Over Risk of the Port Catheters Failing, Causing Severe Injury
Angiodynamics LifePort Lawsuit Filed Over Risk of the Port Catheters Failing, Causing Severe Injury (Posted today)

Complaint comes as a panel of federal judges are scheduled to hear oral arguments later this month, to determine whether all AngioDynamics port catheter lawsuits filed in U.S. District Courts nationwide should be centralized before one judge.

Depo-Provera Meningioma Brain Tumors Risks May Have Been Ignored by Pfizer for Decades
Depo-Provera Meningioma Brain Tumors Risks May Have Been Ignored by Pfizer for Decades (Posted 4 days ago)

After decades of medical research and reported Depo-Provera side effects, Pfizer should have known that its birth control shot increases the risks of meningioma brain tumors, yet failed to warn women or the medical community.